Literature DB >> 17640847

Application of multiple parallel perfused microbioreactors and three-dimensional stem cell culture for toxicity testing.

Z F Cui1, X Xu, N Trainor, J T Triffitt, J P G Urban, U K Tirlapur.   

Abstract

In this study, a multiple parallel perfused microbioreactor platform, TissueFlex, was developed which can be used to perform cell and tissue culture under almost uniform and precisely controlled environment in a mid-throughput and parallel manner. These microbioreactors were used to culture human bone marrow cells (hBMCs) in three-dimensional (3D) scaffolds and also in two-dimensional (2D) monolayer for comparison for upto 7 days. Several scaffolding materials were evaluated for this purpose in terms of easiness in handling, ability to support the hBMC growth, and feasibility for non-destructive optical assays. The feasibility and efficacy of using the developed 3D-hBMCs-based model tissue-constructs cultured in TissueFlex microbioreactors for drug evaluation and toxicity testing was then studied. As a demonstration case study, the cultured cells were challenged with two chemicals, trimethoprim and pyrimethamine, both known to be harmful to cellular activities, with different protocols. Cytotoxicity in terms of cell viability and growth was determined using the AlamarBlue assay. The 3D spatial variations in cell morphology and cell survival were also monitored using 3D optical imaging using non-linear multiphoton microscopy. The results show that (i) the data obtained from 3D hBMCs culture and from (2D) monolayer cultures on the effect of the tested chemicals on cell growth are significantly different, and that (ii) the perfused microbioreactor technology could provide a highly controlled and prolonged cell culture environment for testing of various drugs and chemicals. The outcome of this study demonstrated the feasibility and potentials of the using 3D stem cell based model tissues in TissueFlex microbioreactors for drug evaluation and toxicity testing of chemicals as an efficient and standardized alternative testing method.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17640847     DOI: 10.1016/j.tiv.2007.05.015

Source DB:  PubMed          Journal:  Toxicol In Vitro        ISSN: 0887-2333            Impact factor:   3.500


  11 in total

Review 1.  Developmental neurotoxicity - challenges in the 21st century and in vitro opportunities.

Authors:  Lena Smirnova; Helena T Hogberg; Marcel Leist; Thomas Hartung
Journal:  ALTEX       Date:  2014       Impact factor: 6.043

2.  Noninvasive real-time monitoring by alamarBlue(®) during in vitro culture of three-dimensional tissue-engineered bone constructs.

Authors:  Xiaohua Zhou; Inge Holsbeeks; Saartje Impens; Maarten Sonnaert; Veerle Bloemen; Frank Luyten; Jan Schrooten
Journal:  Tissue Eng Part C Methods       Date:  2013-02-25       Impact factor: 3.056

Review 3.  Biology-inspired microphysiological system approaches to solve the prediction dilemma of substance testing.

Authors:  Uwe Marx; Tommy B Andersson; Anthony Bahinski; Mario Beilmann; Sonja Beken; Flemming R Cassee; Murat Cirit; Mardas Daneshian; Susan Fitzpatrick; Olivier Frey; Claudia Gaertner; Christoph Giese; Linda Griffith; Thomas Hartung; Minne B Heringa; Julia Hoeng; Wim H de Jong; Hajime Kojima; Jochen Kuehnl; Marcel Leist; Andreas Luch; Ilka Maschmeyer; Dmitry Sakharov; Adrienne J A M Sips; Thomas Steger-Hartmann; Danilo A Tagle; Alexander Tonevitsky; Tewes Tralau; Sergej Tsyb; Anja van de Stolpe; Rob Vandebriel; Paul Vulto; Jufeng Wang; Joachim Wiest; Marleen Rodenburg; Adrian Roth
Journal:  ALTEX       Date:  2016-05-15       Impact factor: 6.043

4.  Quantitative Validation of the Presto Blue Metabolic Assay for Online Monitoring of Cell Proliferation in a 3D Perfusion Bioreactor System.

Authors:  Maarten Sonnaert; Ioannis Papantoniou; Frank P Luyten; Jan Ir Schrooten
Journal:  Tissue Eng Part C Methods       Date:  2015-03-31       Impact factor: 3.056

5.  Development of an integrated microfluidic perfusion cell culture system for real-time microscopic observation of biological cells.

Authors:  Lung Lin; Shih-Siou Wang; Min-Hsien Wu; Chih-Chin Oh-Yang
Journal:  Sensors (Basel)       Date:  2011-08-29       Impact factor: 3.576

6.  Three-dimensional perfused tumour spheroid model for anti-cancer drug screening.

Authors:  Xiao Wan; Zhaohui Li; Hua Ye; Zhanfeng Cui
Journal:  Biotechnol Lett       Date:  2016-05-11       Impact factor: 2.461

7.  Novel 2D and 3D Assays to Determine the Activity of Anti-Leishmanial Drugs.

Authors:  Alec O'Keeffe; Christine Hale; James A Cotton; Vanessa Yardley; Kapish Gupta; Abhishek Ananthanarayanan; Sudaxshina Murdan; Simon L Croft
Journal:  Microorganisms       Date:  2020-06-01

8.  Development of a pneumatically driven active cover lid for multi-well microplates for use in perfusion three-dimensional cell culture.

Authors:  Song-Bin Huang; Dean Chou; Yu-Han Chang; Ke-Cing Li; Tzu-Keng Chiu; Yiannis Ventikos; Min-Hsien Wu
Journal:  Sci Rep       Date:  2015-12-16       Impact factor: 4.379

9.  Development of in vitro 3D TissueFlex® islet model for diabetic drug efficacy testing.

Authors:  Zhaohui Li; He Sun; Jianbin Zhang; Haijiao Zhang; Fanyu Meng; Zhanfeng Cui
Journal:  PLoS One       Date:  2013-08-15       Impact factor: 3.240

10.  3D models of the hematopoietic stem cell niche under steady-state and active conditions.

Authors:  Lisa Rödling; Ivo Schwedhelm; Saskia Kraus; Karen Bieback; Jan Hansmann; Cornelia Lee-Thedieck
Journal:  Sci Rep       Date:  2017-07-04       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.